Drug Approval | April 20, 2026
Aurobindo Pharma wins key FDA nod for $138M US cough drug market entry
The drug is designed to provide temporary relief from cough caused by throat and bronchial irritation
The drug is designed to provide temporary relief from cough caused by throat and bronchial irritation
Subscribe To Our Newsletter & Stay Updated